Projects
(Principal Investigator)



Results 1-25 of 25 (Search time: 0.003 seconds).

Start DateTitleP-InvestigatorFunding Organization/經費來源
2022Revealing Pathogenic Mechanisms of Hemodialysis Arteriovenous Fistula MaturationCHIH-CHENG WUNational Science and Technology Council
2021Revealing Pathogenic Mechanisms of Hemodialysis Arteriovenous Fistula MaturationCHIH-CHENG WUNational Science and Technology Council
2020Revealing Pathogenic Mechanisms of Hemodialysis Arteriovenous Fistula MaturationCHIH-CHENG WUNational Science and Technology Council
2015Unraveling the Cellular and Molecular Mechanisms of miR-146a in Atherosclerotic FormationCHIH-CHENG WUNational Science and Technology Council
2015Revealing the Interactions between Uremic Toxin, Endothelium, and Venous Intimal Hyperplasia in Hemodialysis Patients (II)CHIH-CHENG WUNational Science and Technology Council
2015一個多國多中心、隨機、雙盲、安慰劑對照的試驗,以評估一天2次Ticagrelor 90 mg對於第二型糖尿病患者之心血管性死亡、心肌梗塞或中風發生率的效果CHIH-CHENG WUAstraZeneca plc.
2015血液透析血管靜脈內膜增生之病生理研究CHIH-CHENG WUHsin-Chu Branch of National Taiwan University Hospital
2014全球性抗凝血領域登錄研究,觀察經治療後之急性靜脈血栓栓塞病患,其實務上之治療及成果CHIH-CHENG WUThrombosis Research Institute
2014非侵入可攜式無壓脈帶血壓計支準確度驗證CHIH-CHENG WUMaisense
2014Revealing the Interactions between Uremic Toxin, Endothelium, and Venous Intimal Hyperplasia in Hemodialysis PatientsCHIH-CHENG WUNational Science and Technology Council
2014(103CT1026) The Development and Clinical Application of Rapid Assays Using Multi-Antibody-Activated Magnetic Nanoparticles System in Acute Coronary SyndromeCHIH-CHENG WUNational Science and Technology Council
2014一個多中心、單治療組、開放性的第四期臨床試驗,評估Ticagrelor於臺灣非ST段上升型心肌梗塞患者的安全性及說明重大心血管事件之累計發生率CHIH-CHENG WUAstraZeneca plc.
2014Predictors for outcomes of hemodialysis vascular access: Impact of circulating endothelial progenitor cells on access thrombosis, aneurysm dilatation, and access infection.CHIH-CHENG WUHsin-Chu Branch of National Taiwan University Hospital
2013親蛋白質尿毒素對血液透析血管預後的影響CHIH-CHENG WUHsin-Chu Branch of National Taiwan University Hospital
2013心血管生物標記之臨床檢體收集與分析CHIH-CHENG WUIndustrial Technology Research Institute
2012代謝症候生物標記之臨床檢體收集與分析CHIH-CHENG WUIndustrial Technology Research Institute
2012血管內皮功能相關基因之基因型差異與血液透析病患動靜脈廔管血管成型術後再狹窄之關係CHIH-CHENG WUHsin-Chu Branch of National Taiwan University Hospital
2011凝血及組合生物標記臨床檢體比對分析CHIH-CHENG WUIndustrial Technology Research Institute
2011影響血管內皮功能因素與透析通路血管成型術後再狹窄之關係CHIH-CHENG WUHsin-Chu Branch of National Taiwan University Hospital
2010PT凝血時間及HbA1C之臨床樣品比對CHIH-CHENG WUIndustrial Technology Research Institute
2010血管內皮功能相關基因之基因型差異與血液透析病患血管成型術後再狹窄之關係CHIH-CHENG WUHsin-Chu Branch of National Taiwan University Hospital
2010The impact of circulating interleukin-6 before and after angioplasty on the venous restenosis of hemodialysis vascular accessCHIH-CHENG WUHospital and Social Welfare Organizations Administration Commission, MOHW
2010Relation between percutaneous thrombectomy procedures and cardiopulmonary function in hemodialysis patients with history of thrombosed vascular accessCHIH-CHENG WUHsin-Chu Branch of National Taiwan University Hospital
2009Comparison of the Arrow-Trerotola Percutaneous Thrombectomy Device versus the AngioJet Rheolytic Catheter in the treatment of thrombosed native hemodialysis arteriovenous fistulas - A retrospective studyCHIH-CHENG WUHsin-Chu Branch of National Taiwan University Hospital
2007Serum adhesion molecules and restenosis after percutaneous dialysis fistula intervention: a prospective study.CHIH-CHENG WUHsin-Chu Branch of National Taiwan University Hospital